Hypertrophic Cardiomyopathy: A Brief Overview - 19/02/24
Résumé |
Hypertrophic cardiomyopathy (HCM) is a complex, heterogeneous disorder that affects approximately 1 in every 500 persons worldwide and about 750,000 Americans. It is characterized by left ventricular hypertrophy that is usually asymmetric, with enlarged myocytes in disarray, unexplained by loading conditions. Obstruction to left ventricular outflow occurs in approximately 60% of patients. The natural history and cardiac morphology of HCM are quite heterogeneous. Although most patients with HCM are asymptomatic or mildly symptomatic, a minority are disabled by dyspnea, angina, or syncope, develop advanced heart failure, or die suddenly.
Le texte complet de cet article est disponible en PDF.Keywords : HCM, ICD, mortality, sudden cardiac death
Plan
| Please visit AJC-HCM_Supplement to review and complete the evaluation portion of this activity and download your CE certificate. |
|
| This article is published as part of a supplement supported by an independent educational grant from Bristol Myers Squibb to AcademicCME. |
|
| Funding: none. |
Vol 212 - N° S
P. S1-S3 - février 2024 Retour au numéro
Article précédent
- Contents
- Genetic Testing in Hypertrophic Cardiomyopathy
- Catherine G. Ireland, Carolyn Y. Ho
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?